IMRN
Price
$1.86
Change
-$0.03 (-1.59%)
Updated
Sep 5, 04:12 PM (EDT)
Capitalization
10.16M
89 days until earnings call
NONOF
Price
$55.85
Change
-$0.75 (-1.33%)
Updated
Sep 4 closing price
Capitalization
250.23B
Interact to see
Advertisement

IMRN vs NONOF

Header iconIMRN vs NONOF Comparison
Open Charts IMRN vs NONOFBanner chart's image
Immuron
Price$1.86
Change-$0.03 (-1.59%)
Volume$500
Capitalization10.16M
Novo-Nordisk A/S
Price$55.85
Change-$0.75 (-1.33%)
Volume$6.31K
Capitalization250.23B
IMRN vs NONOF Comparison Chart in %
Loading...
IMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NONOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMRN vs. NONOF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMRN is a Hold and NONOF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (IMRN: $1.86 vs. NONOF: $55.85)
Brand notoriety: IMRN and NONOF are both not notable
IMRN represents the Biotechnology, while NONOF is part of the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: IMRN: 4% vs. NONOF: 2%
Market capitalization -- IMRN: $10.16M vs. NONOF: $250.23B
IMRN [@Biotechnology] is valued at $10.16M. NONOF’s [@Pharmaceuticals: Major] market capitalization is $250.23B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $651.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B. The average market capitalization across the [@Pharmaceuticals: Major] industry is $90.72B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMRN’s FA Score shows that 1 FA rating(s) are green whileNONOF’s FA Score has 2 green FA rating(s).

  • IMRN’s FA Score: 1 green, 4 red.
  • NONOF’s FA Score: 2 green, 3 red.
According to our system of comparison, NONOF is a better buy in the long-term than IMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMRN’s TA Score shows that 5 TA indicator(s) are bullish while NONOF’s TA Score has 4 bullish TA indicator(s).

  • IMRN’s TA Score: 5 bullish, 4 bearish.
  • NONOF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both IMRN and NONOF are a good buy in the short-term.

Price Growth

IMRN (@Biotechnology) experienced а +1.53% price change this week, while NONOF (@Pharmaceuticals: Major) price change was -1.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.44%. For the same industry, the average monthly price growth was +9.90%, and the average quarterly price growth was +31.78%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.01%. For the same industry, the average monthly price growth was +3.85%, and the average quarterly price growth was +10.24%.

Reported Earning Dates

IMRN is expected to report earnings on Dec 03, 2025.

Industries' Descriptions

@Biotechnology (+2.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Major (+1.01% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NONOF($250B) has a higher market cap than IMRN($10.2M). IMRN YTD gains are higher at: 9.294 vs. NONOF (-34.980). NONOF has higher annual earnings (EBITDA): 154B vs. IMRN (-7.35M). NONOF has more cash in the bank: 18.9B vs. IMRN (7.74M). NONOF has higher revenues than IMRN: NONOF (312B) vs IMRN (6.54M).
IMRNNONOFIMRN / NONOF
Capitalization10.2M250B0%
EBITDA-7.35M154B-0%
Gain YTD9.294-34.980-27%
P/E RatioN/A14.06-
Revenue6.54M312B0%
Total Cash7.74M18.9B0%
Total DebtN/A99.3B-
FUNDAMENTALS RATINGS
IMRN vs NONOF: Fundamental Ratings
IMRN
NONOF
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
16
Undervalued
PROFIT vs RISK RATING
1..100
10081
SMR RATING
1..100
9715
PRICE GROWTH RATING
1..100
5364
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
19n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NONOF's Valuation (16) in the null industry is in the same range as IMRN (24) in the Biotechnology industry. This means that NONOF’s stock grew similarly to IMRN’s over the last 12 months.

NONOF's Profit vs Risk Rating (81) in the null industry is in the same range as IMRN (100) in the Biotechnology industry. This means that NONOF’s stock grew similarly to IMRN’s over the last 12 months.

NONOF's SMR Rating (15) in the null industry is significantly better than the same rating for IMRN (97) in the Biotechnology industry. This means that NONOF’s stock grew significantly faster than IMRN’s over the last 12 months.

IMRN's Price Growth Rating (53) in the Biotechnology industry is in the same range as NONOF (64) in the null industry. This means that IMRN’s stock grew similarly to NONOF’s over the last 12 months.

NONOF's P/E Growth Rating (98) in the null industry is in the same range as IMRN (100) in the Biotechnology industry. This means that NONOF’s stock grew similarly to IMRN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMRNNONOF
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
68%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 12 days ago
76%
Declines
ODDS (%)
Bearish Trend 17 days ago
89%
Bearish Trend 2 days ago
64%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
54%
Aroon
ODDS (%)
Bearish Trend 2 days ago
78%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
IMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NONOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NCTY9.650.59
+6.57%
The9 Limited
NFE2.450.10
+4.26%
New Fortress Energy
DWTX4.90-0.10
-2.00%
Dogwood Therapeutics Inc
GEO20.63-0.51
-2.41%
GEO Group (The)
AS36.56-1.23
-3.25%
Amer Sports

NONOF and

Correlation & Price change

A.I.dvisor indicates that over the last year, NONOF has been closely correlated with NVO. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if NONOF jumps, then NVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NONOF
1D Price
Change %
NONOF100%
-1.33%
NVO - NONOF
70%
Closely correlated
-1.06%
LABFF - NONOF
23%
Poorly correlated
N/A
IMRN - NONOF
22%
Poorly correlated
+1.61%
QSI - NONOF
21%
Poorly correlated
N/A
VRTX - NONOF
21%
Poorly correlated
+0.08%
More